Latest News
Japan approves Remdesivir for Covid-19 treatment
Japan on Thursday authorised the antiviral drug remdesivir to treat coronavirus patients, the government said, with an eye to approving another medication Avigan this month.
This makes Japan the second country to approve the drug after US regulators authorised it on Friday for emergency use against severe cases of COVID-19.
“Remdesivir was approved under exceptional measures,” a health, labour and welfare ministry official said.
“It was our country’s first such approval for the treatment of coronavirus patients,” the official told AFP.
Prime Minister Shinzo Abe said last week the government was getting ready to give a speedy green light to the experimental drug developed by US firm Gilead Sciences.
The US go-ahead came after a major clinical trial showed remdesivir — originally developed to treat Ebola — shortened the time to recovery in some patients by a third.
The difference in mortality rate was not statistically significant.
Remdesivir, which is administered by injection, was already available to some patients who enrolled in clinical trials around the world.
BREAKING: APC Crisis: Court of Appeal dismisses Moses Agaba’s appeal against Austin Agada
BBNaija’s Phyna publicly rejects family, drops surname
Yemi Alade slams Cool FM, Clout Africa over blacklisting, refusal to forgive
BREAKING: Relief as Lakurawa terrorists flee Nigeria after military intervention
BREAKING: Supreme Court nullifies National Lottery Act, grants states exclusive control
Latest update on fuel price hike, fuel scarcity for November 22nd, 2024
Full List of 80,000 delisted companies published by CAC
Amended NDLEA Act: Senate approves life imprisonment for drug traffickers, rejects death penalty
Monday Odigie steps down as Bendel Insurance coach
Lewandowski reflects on missed Manchester United transfer
Okoye reflects on Super Eagles return after two years
